María González
About María González
María González is the Delegada De Inmuno Oncologia at Bristol-Myers Squibb in New York, with over 25 years of experience in the pharmaceutical industry, specializing in oncology and immuno-oncology.
Current Position at Bristol-Myers Squibb
María González currently serves as Delegada De Inmuno Oncologia at Bristol-Myers Squibb, based in New York, New York, United States. She has been instrumental in driving immuno-oncology initiatives at the company since 2015. In this role, she leverages her extensive experience in oncology and immuno-oncology to support the development and implementation of key strategies within the field.
Previous Roles in the Pharmaceutical Industry
Before joining Bristol-Myers Squibb, María González amassed significant experience working for major pharmaceutical companies. She served as Delegada Hospitalaria at Boehringer Ingelheim from 2008 to 2015. Prior to that, she held the position of Delegada Hospitalaria Oncologia at Novartis from 1998 to 2008, where she contributed to the launch of several key oncology drugs. María also worked as Delegada Hospitalaria at Sanofi-Aventis Deutschland GmbH from 1993 to 1998.
Educational Background and Expertise
María González holds a Master’s degree from Instituto Murciano de Tecnología, earned in 1993. She also attended Instituto de Fomento de la Región de Murcia from 1992 to 1993. Additionally, she completed her undergraduate studies at Universidad de Murcia, where she studied from 1987 to 1992. Her robust educational background in technology and regional development provides a strong foundation for her work in the pharmaceutical industry.
Over 25 Years in Oncology and Immuno-Oncology
With over 25 years of experience in the pharmaceutical industry, María González specializes in oncology and immuno-oncology. Her career has involved significant roles in hospital liaison capacities across various leading pharmaceutical companies. This extensive experience encompasses both the Spanish and international pharmaceutical markets, enhancing her capabilities in driving impactful initiatives within her field.